The COVID-19 pandemic did not adversely affect clinical trial enrollment in gynecologic oncology trials at a single academic institution

por Bailey, Courtney, Ghamande, Sharad, Tran, Lynn, Rungruang, Bunja, Wheatley, Donna, Higgins, Robert
Publicado 2022

Combination CDC-like kinase inhibition (CLK)/Dual-specificity tyrosine-regulated kinase (DYRK) and taxane therapy in CTNNB1-mutated endometrial cancer

por Corr, Bradley R, Moroney, Marisa R, Woodruff, Elizabeth, Watson, Zachary L, Jordan, Kimberly R., Danhorn, Thomas, Bailey, Courtney, Wolsky, Rebecca J, Bitler, Benjamin G
Publicado 2023

Combinatory EHMT and PARP inhibition induces an interferon response and a CD8 T cell-dependent tumor regression in PARP inhibitor-resistant models

por Nguyen, Lily L., Watson, Zachary L., Ortega, Raquel, Woodruff, Elizabeth R., Jordan, Kimberly R., Iwanaga, Ritsuko, Yamamoto, Tomomi M., Bailey, Courtney A., Jeong, Abigail D., Guntupalli, Saketh R., Behbakht, Kian, Gbaja, Veronica, Arnoult, Nausica, Chuong, Edward B., Bitler, Benjamin G.
Publicado 2023